RESULT OF POLYMERASE CHAIN REACTION (PCR) TEST POSITIVITY AND VACCINATION ASSOCIATED WITH INCIDENCE RATE OF COVID-19 IN JEPARA REGENCY

Authors

  • Nurul Adinda Natasya -Public Health Department, Faculty of Medicine, Universitas Negeri Semarang, Indonesia
  • Mahalul Azam Public Health Department, Faculty of Medicine, Universitas Negeri Semarang, Indonesia

DOI:

https://doi.org/10.31004/jkt.v4i4.22127

Keywords:

Covid 19, Vaksinasi

Abstract

COVID-19 merupakan penyakit menular disebabkan oleh virus SARS-CoV-2. Kabupaten Jepara menjadi salah satu wilayah tersebarnya COVID-19 dan telah menerapkan strategi testing serta vaksinasi sebagai upaya penanganan pandemi. Penelitian ini bertujuan untuk mengkaji hubungan tingkat tes positif PCR dan tingkat vaksinasi terhadap laju insidensi COVID-19 di Kabupaten Jepara. Penelitian ini menggunakan pendekatan kuantitatif dengan desain cross-sectional. Unit analisis penelitian ini merupakan periode waktu dalam satuan minggu. Populasi dan sampel berupa data sekunder angka kasus COVID-19, hasil tes PCR, dan vaksinasi COVID-19 yang tercatat di Dinas Kesehatan Kabupaten Jepara pada 1 Juni 2020 sampai 30 Juni 2022, dengan menggunakan teknik total sampling. Instrumen penelitian berupa lembar pencatatan. Hasil uji korelasi Spearman diperoleh adanya korelasi positif yang sangat kuat antara tingkat tes positif PCR dengan laju insidensi COVID-19 (r=0,810). Terdapat hubungan antara tingkat vaksinasi dengan laju insidensi COVID-19 di Kabupaten Jepara dengan arah korelasi negatif yaitu dosis pertama (r=-0,603) berkorelasi kuat, dosis kedua berkorelasi sedang (r=-0,591), dosis ketiga (r=-0,311) berkorelasi lemah. Simpulan penelitian ini adalah terdapat hubungan antara tingkat tes positif PCR dan tingkat vaksinasi dengan laju insidensi COVID-19 di Kabupaten Jepara.

References

Adesta, G., Kengsiswoyo, N., Zailani, S., Rahadi, R. A., Arief, N. N., & Harapan, P. (2021). Factors influencing COVID-19 vaccine acceptance in Indonesia?: an adoption of Technology Acceptance Model [ version 2?; peer review?: 2 approved ] Taufik Faturohman Harapan Harapan. F1000 Research, 10(476), 1–23.

Al Dallal, A., AlDallal, U., & Al Dallal, J. (2021). Positivity rate: an indicator for the spread of COVID-19. Current Medical Research and Opinion, 37(12), 2067–2076. https://doi.org/10.1080/03007995.2021.1980868

Alharbi, N. K., Al-Tawfiq, J. A., Alghnam, S., Alwehaibe, A., Alasmari, A., Alsagaby, S. A., Alsubaie, F., Alshomrani, M., Farahat, F. M., Bosaeed, M., Alharbi, A., Aldibasi, O., & Assiri, A. M. (2022). Outcomes of single dose COVID-19 vaccines: Eight month follow-up of a large cohort in Saudi Arabia. Journal of Infection and Public Health, 15(5), 573–577. https://doi.org/10.1016/j.jiph.2022.04.001

Andriani, H. (2020). Effectiveness of Large-Scale Social Restrictions (PSBB) toward the New Normal Era during COVID-19 Outbreak: a Mini Policy Review. Journal of Indonesian Health Policy and Administration, 5(2), 61–65. https://doi.org/10.7454/ihpa.v5i2.4001

Chen, Y. T. (2021). The effect of vaccination rates on the infection of covid-19 under the vaccination rate below the herd immunity threshold. International Journal of Environmental Research and Public Health, 18(14). https://doi.org/10.3390/ijerph18147491

Cuadros, D. F., Miller, F. D. W., Awad, S., Coule, P., & MacKinnon, N. J. (2022). Analysis of Vaccination Rates and New COVID-19 Infections by US County, July-August 2021. JAMA Network Open, 5(2), 17–20. https://doi.org/10.1001/jamanetworkopen.2021.47915

Dinkes Jepara. (2022). Sebaran Kasus COVID-19 Kabupaten Jepara. Jepara Tanggap COVID-19. https://corona.jepara.go.id/

Erdal, D., & ?a?maz, C. T. (2022). The evaluation of the correlation between the first dose Covid-19 vaccine coverage rate and weekly Covid-19 incidence in the cities in Turkey. Turk Journal Public Health 2022;20(2), 20(2), 259–271. https://doi.org/10.20518/tjph.1018929

Firmansyah, M. I., Rahmanto, F., & Setiawan, D. (2020). the Preparedness for the Covid-19 Pandemic Management in Indonesia. Jurnal Administrasi Kesehatan Indonesia, 8(2), 188. https://doi.org/10.20473/jaki.v8i2.2020.188-201

Furuse, Y., Ko, Y. K., Ninomiya, K., Suzuki, M., & Oshitani, H. (2021). Relationship of test positivity rates with covid?19 epidemic dynamics. International Journal of Environmental Research and Public Health, 18(9). https://doi.org/10.3390/ijerph18094655

Goldwire, M. A., & Leeds, M. K. (2022). COVID-19 Infection in Children and Adolescents. U.S. Pharmacist, 47(8), 47–55.

Krsemer, M., Yang, C. H., Gutierrez, B., Klein, B., & Pigott, D. M. (2020). The effect of human mobility and control measures on the COVID-19 epidemic in China. Liquid Crystals, 21(1), 1–17.

Li, Z., Liu, X., Liu, M., Wu, Z., Liu, Y., Li, W., Liu, M., Wang, X., Gao, B., Luo, Y., Li, X., Tao, L., Wang, W., & Guo, X. (2021). The effect of the covid-19 vaccine on daily cases and deaths based on global vaccine data. Vaccines, 9(11), 1–12. https://doi.org/10.3390/vaccines9111328

Malesza, M. (2021). Factors influencing COVID-19 vaccination uptake in an elderly sample in Poland. MedRxiv, 1–19.

Mehta, S. H., Clipman, S. J., Wesolowski, A., & Solomon, S. S. (2021). Holiday gatherings, mobility and SARS-CoV-2 transmission: results from 10 US states following Thanksgiving. Scientific Reports, 11(1), 1–9. https://doi.org/10.1038/s41598-021-96779-6

Niu, S., Tian, S., Lou, J., Kang, X., Zhang, L., Lian, H., & Zhang, J. (2020). Clinical characteristics of older patients infected with COVID-19: A descriptive study Shengmei. Archives of Gerontology and Geriatrics, 89(January), 1–5.

Nugraha, B., Wahyuni, L. K., Laswati, H., Kusumastuti, P., Tulaar, A. B., & Gutenbrunner, C. (2020). COVID-19 pandemic in Indonesia: Situation and challenges of rehabilitation medicine in Indonesia. Acta Medica Indonesiana, 52(3), 299–305.

Obi, A. I., Ononigwe, P., Ireye, F., Okundia, P., Irowa, O., Eboreime, H., Tobin, E., Iruobe, L., Osa, B., Okhuarobo, U., & Okoduwa, K. (2021). Positivity Rate as a Performance Indicator for COVID-19 Response in Edo State, Nigeria. Asian Journal of Research in Infectious Diseases, 8(3), 24–30. https://doi.org/10.9734/ajrid/2021/v8i330240

Ophinni, Y., Hasibuan, A. S., Widhani, A., Maria, S., Koesnoe, S., Yunihastuti, E., Karjadi, T. H., Rengganis, I., & Djauzi, S. (2020). COVID-19 Vaccines: Current Status and Implication for Use in Indonesia. Acta Medica Indonesiana, 52(4), 388–412.

Pemprov Jateng. (2022). Data Assesmen Level Jawa Tengah. Tanggap COVID-19 Provinsi Jawa Tengah. https://corona.jatengprov.go.id/

Petros, G., Vraka, I., Olga, S., & Konstantakopoulouc, O. (2021). Predictors of COVID-19 vaccination uptake and reasons for decline of vaccination: a systematic review Running. MedRxiv, 1–33.

Pilecco, F. B., Coelho, C. G., Fernandes, Q. H. R. F., Silveira, I. H., Pescarini, J. M., Ortelan, N., Gabrielli, L., Aquino, E. M. L., & Barreto, M. L. (2021). The effect of laboratory testing on COVID-19 monitorinindicators: an analysis of the 50 countries with the highest number of cases*. Epidemiologia e Servicos de Saude, 30(2), 1–10. https://doi.org/10.1590/S1679-49742021000200002

Ponnaiah, M., Abdulkader, R. S., Bhatnagar, T., Thangaraj, J. W. V., Kumar, M. S., Sabarinathan, R., Velusamy, S., Sabde, Y., Singh, H., & Murhekar, M. V. (2021). COVID-19 testing, timeliness and positivity from ICMR’s laboratory surveillance network in India: Profile of 176 million individuals tested and 188 million tests, March 2020 to January 2021. PLoS ONE, 16(12 December), 1–19. https://doi.org/10.1371/journal.pone.0260979

Porte, L., Legarraga, P., Vollrath, V., Aguilera, X., Munita, J. M., Araos, R., Pizarro, G., Vial, P., Iruretagoyena, M., Dittrich, S., & Weitzel, T. (2020). Evaluation of a novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples. International Journal of Infectious Diseases, 99, 328–333. https://doi.org/10.1016/j.ijid.2020.05.098

Rannan-Eliya, R. P., Wijemunige, N., Gunawardana, J. R. N. A., Amarasinghe, S. N., Sivagnanam, I., Fonseka, S., Kapuge, Y., & Sigera, C. P. (2021). Increased intensity of

PCR testing reduced covid-19 transmission within countries during the first pandemic wave. Health Affairs, 40(1), 70–81. https://doi.org/10.1377/hlthaff.2020.01409

Reno, C., Lenzi, J., Golinelli, D., Gori, D., Signorelli, C., Kraemer, J., Stoto, M. A., Avitabile, E., Landini, M. P., Lazzarotto, T., Carla Re, M., Rucci, P., Taliani, G., Trerè, D., Vocale, C., & Fantini, M. P. (2020). SARS-CoV-2/COVID-19 testing: The tower of babel. Acta Biomedica, 91(4), 1–10. https://doi.org/10.23750/abm.v91i4.10911

Satuan Tugas Penanganan COVID-19. (2021). Pengendalian COVID-19 Dengan 3M, 3T, Vaksinasi, Disiplin, Kompak, dan Konsisten.

Setiawan, M. Y. (2022). Ini Penyebab Capaian Vaksinasi Booster di Jepara Masih Rendah, Baru Capai 17,78 Persen. Tribun Jateng. https://www.google.com/amp/s/jateng.tribunnews.com/amp/2022/07/13/ini-penyebab-capaian-vaksinasi-booster-di-jepara-masih-rendah-baru-capai-1778-persen

Sohrabi, C., Alsafi, Z., O’Neill, N., Khan, M., Kerwan, A., Al-Jabir, A., Iosifidis, C., & Agha, R. (2020). World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). International Journal of Surgery, 76(February), 71–76. https://doi.org/10.1016/j.ijsu.2020.02.034

Subramanian, S. V., & Kumar, A. (2021). Increases in COVID-19 are unrelated to levels of vaccination across 68 countries and 2947 counties in the United States. European Journal of Epidemiology, 36(12), 1237–1240. https://doi.org/10.1007/s10654-021-00808-7

Sucahya, P. K. (2020). Barriers to Covid-19 RT-PCR Testing in Indonesia: A Health Policy Perspective. Journal of Indonesian Health Policy and Administration, 5(2), 36–42. https://doi.org/10.7454/ihpa.v5i2.3888

Toharudin, T., Pontoh, R. S., Caraka, R. E., Zahroh, S., Kendogo, P., Sijabat, N., Sari, M. D. P., Gio, P. U., Basyuni, M., & Pardamean, B. (2021). National vaccination and local intervention impacts on covid-19 cases. Sustainability (Switzerland), 13(15). https://doi.org/10.3390/su13158282

Torjesen, I. (2021). Covid-19: Omicron may be more transmissible than other variants and partly resistant to existing vaccines, scientists fear. BMJ (Clinical Research Ed.), 375(4), n2943. https://doi.org/10.1136/bmj.n2943

Tunas, I. K., Laksemi, D. A. A. S., Widyadharma, I. P. E., & Sundari, L. P. R. (2021). The efficacy of covid-19 vaccine and the challenge in implementing mass vaccination in indonesia. International Journal of Applied Pharmaceutics, 13(4), 74–76. https://doi.org/10.22159/ijap.2021v13i4.41270

Utami, A. (2022). Determinant Factors of COVID-19 Vaccine Hesitancy Among Adult and Elderly Population in Central Java , Indonesia. June, 1559–1570.

Vasileiou, E., Simpson, C. R., Shi, T., Kerr, S., Agrawal, U., Akbari, A., Bedston, S., Beggs, J., Bradley, D., Chuter, A., Lusignan, S. De, Docherty, A. B., Ford, D., Hobbs, F. D. R., Joy, M., Katikireddi, S. V., Marple, J., Mccowan, C., Mcgagh, D., … Stock, S. (2021). Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland?: a national prospective cohort study. The Lancet, 397(10285), 1646–1657. https://doi.org/10.1016/S0140-6736(21)00677-2

WHO. (2020). Overview of public health and social measures in the context of COVID-19. World Health Organization 2020., May, 1–8.

WHO. (2022). COVID-19 Weekly Epidemiological Update. World Health Organization, February, 1–33.

Downloads

Published

2023-12-29

How to Cite

Natasya, N. A. ., & Azam, M. . (2023). RESULT OF POLYMERASE CHAIN REACTION (PCR) TEST POSITIVITY AND VACCINATION ASSOCIATED WITH INCIDENCE RATE OF COVID-19 IN JEPARA REGENCY. Jurnal Kesehatan Tambusai, 4(4), 6858–6868. https://doi.org/10.31004/jkt.v4i4.22127

Issue

Vol. 4 No. 4 (2023): DESEMBER 2023

Section

Articles

License

Copyright (c) 2023 Nurul Adinda Natasya, Mahalul Azam

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Authors who publish with this journal agree to the following terms:

  • Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
  • Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  • Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).